← Back to Clinical Trials
Recruiting NCT06896903

NCT06896903 Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06896903
Status Recruiting
Phase
Sponsor Baylor Research Institute
Condition ANOCA - Angina With Non-obstructive Coronary Arteries
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-05-21
Primary Completion 2026-05-01

Trial Parameters

Condition ANOCA - Angina With Non-obstructive Coronary Arteries
Sponsor Baylor Research Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-21
Completion 2026-05-01
Interventions
Coronary reactivity testing with and without nitrates

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This single-arm, multi-center, prospective study will assess the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and determinants thereof (transit time, Pa, Pd) in patients before and after intracoronary nitroglycerine.

Eligibility Criteria

Inclusion Criteria: 1. Aged 18 or older 2. Patient being evaluated for ANOCA or INOCA 3. Clinical suspicion for angina 4. Patient should be able to comply with the protocol. 5. Provide written informed consent before study participation. Exclusion Criteria: 1. Existing coronary artery disease 2. Previous percutaneous interventions within the coronaries 3. Current use (within 48 hours) of long-acting nitrate therapies 4. Current use (within 48 hours) of PDE-5 inhibitors (sildenafil, tadalafil) 5. Any other condition or co-morbidity which, in the opinion of the investigator or operator, may pose a significant hazard to the subject if he or she is enrolled in the study. 6. Children below 18 years, prisoners, pregnant people and patients who are unable to provide consent are excluded.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology